IGC Pharma Inc [AMEX: IGC] stock went on an upward path that rose over 15.74% on Wednesday, amounting to a one-week price increase of more than 25.74%.
Over the last 12 months, IGC stock rose by 34.35%. The one-year IGC Pharma Inc stock forecast points to a potential upside of 90.0. The average equity rating for IGC stock is currently 1.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $41.00 million, with 84.14 million shares outstanding and 66.30 million shares in the current float. Compared to the average trading volume of 2.63M shares, IGC stock reached a trading volume of 12200038 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on IGC Pharma Inc [IGC]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for IGC shares is $4.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on IGC stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Price to Book ratio for the last quarter was 6.25, with the Price to Cash per share for the same quarter was set at 0.00.
IGC Stock Performance Analysis:
IGC Pharma Inc [IGC] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 25.74. With this latest performance, IGC shares gained by 22.00% in over the last four-week period, additionally plugging by 58.94% over the last 6 months – not to mention a rise of 34.35% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for IGC stock in for the last two-week period is set at 73.50, with the RSI for the last a single of trading hit 0.0312, and the three-weeks RSI is set at 0.0270 for IGC Pharma Inc [IGC]. The present Moving Average for the last 50 days of trading for this stock 0.3495, while it was recorded at 0.3863 for the last single week of trading, and 0.3293 for the last 200 days.
Insight into IGC Pharma Inc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and IGC Pharma Inc [IGC] shares currently have an operating margin of -524.11% and a Gross Margin at 4.60%. IGC Pharma Inc’s Net Margin is presently recorded at -477.92%.
IGC Pharma Inc (IGC) Capital Structure & Debt Analysis
According to recent financial data for IGC Pharma Inc. ( IGC), the Return on Equity (ROE) stands at -90.87%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -68.43%, reflecting the company’s efficiency in generating profits from its assets. Additionally, IGC Pharma Inc’s Return on Invested Capital (ROIC) is -101.99%, showcasing its effectiveness in deploying capital for earnings.
IGC Pharma Inc (IGC) Efficiency & Liquidity Metrics
Based on IGC Pharma Inc’s (IGC) latest financial statements, the Debt-to-Equity Ratio is 0.03%, indicating its reliance on debt financing relative to shareholder equity.
IGC Pharma Inc (IGC) Efficiency & Liquidity Metrics
From an operational efficiency perspective, IGC Pharma Inc. (IGC) effectively leverages its workforce, generating an average of -$90571.43 per employee. The company’s liquidity position is robust, with a Current Ratio of 1.25% and a Quick Ratio of 0.46%, indicating strong ability to cover short-term liabilities.
IGC Pharma Inc [IGC] Institutonal Ownership Details
There are presently around $18.55%, or 20.26%% of IGC stock, in the hands of institutional investors. The top three institutional holders of IGC stocks are: BLACKROCK INC. with ownership of 0.7 million shares, which is approximately 1.1961%. VANGUARD GROUP INC, holding 0.65 million shares of the stock with an approximate value of $$0.28 million in IGC stocks shares; and VANGUARD GROUP INC, currently with $$0.19 million in IGC stock with ownership which is approximately 0.7305%.
